Latest News


Each news article below shows only part of the news story. To view the full story, click on Read More below the story. 

  • June 07, 2019 7:41 AM | Anonymous

    June 7, 2019, HealthDay News

    THURSDAY, June 6, 2019 (HealthDay News) -- Wendy Lybarger lived an hour's drive from the hospital where her breast cancer would be treated, so she was looking forward to a heaping helping of hassle.

    For as many as six weeks, she'd have to travel there every weekday to receive radiation treatments after surgery to remove the small lump in her breast.

    Read more.
  • June 04, 2019 9:01 AM | Anonymous

    June 4, 2019, Medscape 

    Both passive and active thoughts of suicide occur concurrently in a subset of women with premenstrual syndrome, new research suggests. The findings were presented at the American Society of Clinical Psychopharmacology (ASCP) 2019 annual meeting. 

    Read more.

  • June 04, 2019 8:59 AM | Anonymous

    June 4, 2019, Medscape 

    It's not often that a systemic oral therapy significantly improves overall survival (OS) in the setting of metastatic cancer. And, in the case of CDK4/6 inhibitors for breast cancer, it was looking like one might not do so, as multiple previous trials were limited to a significant improvement in progression-free survival.

    Read more.

  • June 04, 2019 8:57 AM | Anonymous

     June 4, 2019, HemOnc Today  

    Data from two trials evaluating the safety and efficacy of adoptive cell transfer with autologous tumor-infiltrating lymphocytes showed promising overall response rates for the treatment of advanced metastatic melanoma and cervical cancer, according to results presented at ASCO Annual Meeting. 

    Read more.

  • June 03, 2019 8:50 AM | Anonymous

    June 3, 2019, MedPage Today 

    CHICAGO -- Adding ribociclib (Kisqali) to endocrine therapy significantly prolonged survival in women with advanced HR-positive/HER-negative breast cancer, with a 29% lower risk of death, a researcher reported here. 

    Read more.

  • May 28, 2019 8:59 AM | Anonymous

    May 28, 2019, MedPage Today 

    Among all U.S. women, rates of more aggressive non-endometrioid cancer subtypes have been rising rapidly. And trends show marked racial differences and disparities, with higher rates of uterine corpus subtypes and poorer survival among non-Hispanic black women, according to a new study in the Journal of Clinical Oncology.

    Read more.

  • May 28, 2019 8:57 AM | Anonymous

    May 28, 2019, MedPage Today 

    Two diagnostic tests for gonorrhea and chlamydia infection may be used with throat and rectal samples, the U.S. Food and Drug Administration said on May 23. Hologic's Aptima Combo 2 Assay and the Cepheid Xpert CT/NG had previously been cleared for diagnostic testing to detect Chlamydia trachomatis and Neisseria gonorrhoeae in urine, vaginal and endocervical samples. The FDA noted that no chlamydia or gonorrhea tests had been cleared for use on samples from the throat and rectum. 

    Read more.

  • May 24, 2019 1:45 PM | Anonymous

    May 24, 2019 

    APAOG Board member Heather Adams, MPAS, PA-C, recently presented the webinar Centering Pregnancy: A Group Healthcare Model for Prenatal Care published by Elsevier. In addition, she also contributed to the Women’s Health, An Issue of Physician Assistant Clinics, 1st Edition in 2018.

    Access the free webinar via youtube by clicking here.

    Issues of Women's Health, An Issue of Physician Assistant Clinics 1st Edition are available for purchase from Elsevier here.

    Heather currently serves as the APAOG Publications Chair. Heather is currently a practicing Physician Assistant at Women's Wellness & Gynecology and serves as an Associate Professor in the Physician Assistant Program at Gannon University in Erie, PA. 

  • May 24, 2019 10:12 AM | Anonymous

    May 24, 2019, MedPage Today 

    Immunotherapy is emerging as a new treatment option in breast cancer, with improved understanding of immune evasion by cancer cells and the discovery of selective immune checkpoint inhibitors creating novel opportunities for treatment. 

    Read more.

  • May 24, 2019 10:11 AM | Anonymous

    May 24, 2019, Medical Xpress 

    Women experiencing a minor stroke or transient ischemic attack (TIA) are less likely to be diagnosed with a stroke compared to men — even though they describe similar symptoms in emergency departments. In the study, men were more likely to be diagnosed with TIA or minor stroke, and women were 10% more likely to be given a non-stroke diagnosis, for example migraine or vertigo, even though men and women were equally likely to report atypical stroke symptoms. 

    Read more.

Powered by Wild Apricot Membership Software